SCHEMBL1628901

SCHEMBL1628901

[CH2]C(O)NCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899403 0.97 CA12 (0.33)
SCHEMBL27074384 0.85 CA12 (0.52)
SCHEMBL123824 0.75
SCHEMBL9911185 0.75 CA12 (0.39)
SCHEMBL24400179 0.73
SCHEMBL27480934 0.73
SCHEMBL28185696 0.73
SCHEMBL28866382 0.72
SCHEMBL6403719 0.71
SCHEMBL5549574 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970005-A1 ENVIRONMENTALLY FRIENDLY PERMANENT QUATERNARIES OF POLYAMINES AND THEIR USE AS CLAY STABILIZERS AND METHODS FOR MAKING AND USING SAME Clearwater International LLC (US) 2016-01-20 EP claimed
WO-2014144387-A1 ENVIRONMENTALLY FRIENDLY PERMANENT QUATERNARIES OF POLYAMINES AND THEIR USE AS CLAY STABILIZERS AND METHODS FOR MAKING AND USING SAME CLEARWATER INTERNATIONAL, LLC (US) 2014-09-18 WO claimed
US-20080038349-A1 Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase ITSCHAK LAMENSDORF 2008-02-14 US claimed
EP-1680439-A2 DUAL PHASE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER Kernel Biopharma Inc. (IL) 2006-07-19 EP claimed
EP-1680438-A2 AMIPHIPHYLIC PEPTIDE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER Kernel Biopharma Inc. (IL) 2006-07-19 EP claimed
US-20060142227-A1 Amphiphylic peptide-PNA conjugates for the delivery of PNA through the blood brain barrier LAMENSDORF ITSCHAK 2006-06-29 US claimed
US-20050222009-A1 Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrier LAMENSDORF ITSCHAK 2005-10-06 US claimed
WO-2005076732-A2 PEPTIDE-PNA CHIMERA TARGETING INDUCIBLE NITRIC OXIDE SYNTHASE KERNEL BIOPHARMA INC. (IL) 2005-08-25 WO claimed
WO-2005035549-A2 AMIPHIPHYLIC PEPTIDE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER KERNEL BIOPHARMA INC. (IL) 2005-04-21 WO claimed
WO-2005035550-A2 DUAL PHASE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER KERNEL BIOPHARMA INC. (IL) 2005-04-21 WO claimed
US-10729638-B2 Powder hair dye composition HOYU CO., LTD. (JP) 2020-08-04 US disclosed
US-20190328646-A1 POWDER HAIR DYE COMPOSITION HOYU CO., LTD. (JP) 2019-10-31 US disclosed
CN-109922784-A OILY COMPOSITION AND OILY COSMETIC 株式会社资生堂 2019-06-21 CN disclosed
US-20190175461-A1 POWDER HAIR DYE COMPOSITION HOYU CO., LTD. (JP) 2019-06-13 US disclosed
CN-109640945-A Composition is used in the improvement of gynecoid type epilation disease 株式会社山田养蜂场本社 2019-04-16 CN disclosed
EP-1557159-A1 SKIN PREPARATIONS FOR EXTERNAL USE SHISEIDO COMPANY LIMITED (JP) 2005-07-27 EP disclosed
WO-2005035549-A2 AMIPHIPHYLIC PEPTIDE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER KERNEL BIOPHARMA INC. (IL) 2005-04-21 WO disclosed
WO-2005035550-A2 DUAL PHASE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER KERNEL BIOPHARMA INC. (IL) 2005-04-21 WO disclosed
US-6676932-B2 CONTAINING PYRIDAZINE DERIVATIVE SUNSCREEN AGENT SHISEIDO CO., LTD. (JP) 2004-01-13 US disclosed
CN-1373797-A adhesive sheet and adhesive sheet for covering 3M INNOVATIVE PROPERTIES CO (US) 2002-10-09 CN disclosed